| abstract |
The present invention relates to triazene analogues of formula (I) and formula (II), tautomeric forms thereof, for metastatic malignant melanoma and other cancers including but not limited to lymphoma, sarcoma, carcinoma, and glioma , Stereoisomers, polymorphs, hydrates, solvates, and pharmaceutically acceptable salts thereof. The present invention also discloses a process for preparing the triazane analogues of the above formulas (I) and (II), and pharmaceutically acceptable compositions thereof. |